000 01439 a2200385 4500
005 20250514074631.0
264 0 _c20040128
008 200401s 0 0 eng d
022 _a1537-453X
024 7 _a10.1097/01.COC.0000026485.57632.1E
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAhmed, Shazia
245 0 0 _aSuccessful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cAug 2003
300 _a408-10 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
650 0 4 _aAntigens, CD20
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aDuodenal Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aRituximab
650 0 4 _aTreatment Failure
700 1 _aSingh, Aman
700 1 _aKrauss, John
700 1 _aWentz, Tracey
700 1 _aGunaratnam, Naresh T
773 0 _tAmerican journal of clinical oncology
_gvol. 26
_gno. 4
_gp. 408-10
856 4 0 _uhttps://doi.org/10.1097/01.COC.0000026485.57632.1E
_zAvailable from publisher's website
999 _c12677896
_d12677896